Sudeep Pharma Limited (BOM:544619)

Sudeep Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	267.39	368.07	139.76	103.01	214.74
Short-Term Investments	-	879.06	150	-	-	-
Trading Asset Securities	-	-	1.36	1.27	30.33	-
Cash & Short-Term Investments	1,146	1,146	519.43	141.03	133.34	214.74
Cash Growth	98.32%	120.71%	268.32%	5.77%	-37.91%	654176.23%
Accounts Receivable	-	2,275	1,854	1,446	937.12	1,066
Other Receivables	-	441.25	313.39	231.64	320.71	111.51
Receivables	-	2,720	2,170	1,690	1,268	1,185
Inventory	-	2,160	1,287	665.82	709.97	365.35
Prepaid Expenses	-	56.47	88.32	18.51	13.73	4.98
Other Current Assets	-	156.64	176.82	237.86	175.58	191.77
Total Current Assets	-	6,240	4,241	2,754	2,300	1,962
Property, Plant & Equipment	-	4,469	2,773	2,246	1,838	1,459
Long-Term Investments	-	152.68	3.33	3.2	2.05	1.94
Goodwill	-	682.4	-	-	-	-
Other Intangible Assets	-	67.53	2.1	3.02	3.95	-
Long-Term Deferred Tax Assets	-	4.95	3.25	2.28	5.44	4.74
Other Long-Term Assets	-	132.2	148.43	130.62	51.49	22.88
Total Assets	-	11,749	7,172	5,139	4,201	3,450

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	684.28	604.8	507.1	384.96	305.54
Accrued Expenses	-	66.58	47.85	40.71	514.57	578.16
Short-Term Debt	-	1,019	852.88	548.3	518.17	484.8
Current Portion of Long-Term Debt	-	121.21	104.13	97.16	104.97	70
Current Portion of Leases	-	7.98	6.44	7.51	2.86	2.2
Current Income Taxes Payable	-	9.84	27.88	1.72	20.04	9.66
Other Current Liabilities	-	110.93	103.59	170.11	162.72	24.83
Total Current Liabilities	-	2,020	1,748	1,373	1,708	1,475
Long-Term Debt	-	342.86	395.53	111.43	199.41	282.34
Long-Term Leases	-	13.37	16.55	22.99	5.42	8.28
Pension & Post-Retirement Benefits	-	0.39	2.9	3.94	-	2.12
Long-Term Deferred Tax Liabilities	-	94.03	63.59	58.47	51.33	48.48
Other Long-Term Liabilities	-	297.58	14.64	9.27	3.83	5.54
Total Liabilities	-	2,768	2,241	1,579	1,968	1,822

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	112.95	97.23	14.09	14.09	14.09
Additional Paid-In Capital	-	2,490	-	98.56	98.56	98.56
Retained Earnings	-	6,287	4,856	3,478	2,150	1,527
Comprehensive Income & Other	-	-56.76	-21.85	-30.74	-30.08	-11.18
Total Common Equity	8,833	8,833	4,931	3,560	2,233	1,628
Minority Interest	-	147.54	-	-	-	-
Shareholders' Equity	8,981	8,981	4,931	3,560	2,233	1,628
Total Liabilities & Equity	-	11,749	7,172	5,139	4,201	3,450

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,504	1,504	1,376	787.39	830.83	847.62
Net Cash (Debt)	-357.77	-357.77	-856.1	-646.37	-697.49	-632.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.18	-3.21	-7.89	-5.96	-6.43	-5.83
Filing Date Shares Outstanding	112.95	112.95	97.23	31	1.41	1.41
Total Common Shares Outstanding	112.95	112.95	97.23	31	1.41	1.41
Working Capital	-	4,220	2,494	1,381	591.89	486.41
Book Value Per Share	78.21	78.21	50.72	114.84	1584.59	1155.38
Tangible Book Value	8,083	8,083	4,929	3,557	2,229	1,628
Tangible Book Value Per Share	71.57	71.57	50.69	114.74	1581.79	1155.38
Land	-	133.17	133.17	132.89	131.5	68.48
Buildings	-	1,188	896.82	840.79	702.97	684.18
Machinery	-	1,191	875.05	783.77	652.02	467.49
Construction In Progress	-	1,784	882.17	446.61	259.72	81.27
Leasehold Improvements	-	30.76	30.76	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error